SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

FDA Grants Priority Review to AstraZeneca’s Sonesitatug Vedotin

The FDA granted priority review to AstraZeneca’s sonesitatug vedotin for advanced gastric cancers.

Related stories